breast neoplasms
Showing NaN - NaN of 46
Breast Tumors, Breast Cancer Trial in Busan, Seoul (Breast MRI for Breast Cancer Detection)
Not yet recruiting
- Breast Neoplasms
- Breast Cancer
- Breast MRI for Breast Cancer Detection
-
Busan, BusanJin-Gu, Korea, Republic of
- +3 more
Apr 2, 2023
Breast Tumors, Breast Cancer, HER2-positive Early Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan, Paclitaxel,
Recruiting
- Breast Neoplasms
- +2 more
- Trastuzumab Deruxtecan
- +5 more
-
Springdale, Arkansas
- +203 more
Jan 13, 2023
Breast Tumors Trial in Israel, Korea, Republic of, United States (Atezolizumab (MPDL3280A), an engineered anti-programmed
Active, not recruiting
- Breast Neoplasms
- Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (PD-L1) antibody
- +7 more
-
Birmingham, Alabama
- +26 more
Dec 21, 2022
Breast Tumors Trial in Worldwide (PD-0332991, Letrozole, Placebo)
Active, not recruiting
- Breast Neoplasms
- PD-0332991
- +2 more
-
Bellflower, California
- +304 more
Dec 6, 2022
Breast Tumors Trial in Worldwide (Abemaciclib, Fulvestrant, Placebo)
Active, not recruiting
- Breast Neoplasms
- Abemaciclib
- +2 more
-
Fayetteville, Arkansas
- +141 more
Nov 15, 2022
Breast Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane)
Completed
- Breast Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
- +3 more
-
Yuma, Arizona
- +93 more
Nov 4, 2022
Breast Tumors, Tumor Metastasis Trial in Worldwide (Imlunestrant, Exemestane, Fulvestrant)
Recruiting
- Breast Neoplasms
- Neoplasm Metastasis
- Imlunestrant
- +3 more
-
Chandler, Arizona
- +238 more
Aug 17, 2022
Breast Tumors Trial in Worldwide (pembrolizumab, paclitaxel, nab-paclitaxel)
Recruiting
- Breast Neoplasms
- pembrolizumab
- +6 more
-
Tucson, Arizona
- +188 more
Aug 11, 2022
Breast Tumors Trial in Worldwide (Palbociclib, Placebo, Tamoxifen)
Active, not recruiting
- Breast Neoplasms
- Palbociclib
- +3 more
-
Nagoya, Aichi, Japan
- +22 more
Apr 4, 2022
Breast Tumors, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Worldwide (talazoparib, Physician's-Choice)
Completed
- Breast Neoplasms
- +2 more
-
Flagstaff, Arizona
- +361 more
Dec 20, 2021
Breast Tumors Trial in Seoul (Olaparib, Durvalumab)
Active, not recruiting
- Breast Neoplasms
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jun 18, 2021
MAstectomy With Reconstruction Including Robot Endoscopic
Recruiting
- Breast Neoplasms
- +4 more
- Robotic or endoscopic nipple sparing mastectomy
- Conventional mastectomy (including nipple sparing mastectomy, skin sparing mastectomy)
-
Seoul, Korea, Republic ofYonsei University College of Medicine
Jun 4, 2021
Breast Tumors Trial in Seoul (Internal mammary node irradiation, No internal mammary node irradiation)
Active, not recruiting
- Breast Neoplasms
- Internal mammary node irradiation
- No internal mammary node irradiation
-
Seoul, Korea, Republic ofYonsei Severance Hospital
Mar 16, 2021
Breast Tumors Trial in Worldwide (Ipatasertib, Paclitaxel, Placebo)
Breast Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Background hormonal therapy)
Terminated
- Breast Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
- +2 more
-
Bakersfield, California
- +70 more
Jul 29, 2020
Testing BRCA 1/2 Mutation Using Next Generation Sequencing
Completed
- Breast Neoplasms
- Breast Cancer
-
Seoul, Korea, Republic ofYonsei University College of Medicine
Oct 3, 2019
Biological Linkage Between Circadian Disruption and Cancer
Completed
- Breast Neoplasms
-
Seoul, Jongno-gu, Korea, Republic ofSeoul National University Hospital
Sep 22, 2019
Hot Flashes, Breast Tumors Trial in Goyang, Seongnam, Seoul (Desvenlafaxine succinate 100mg, Desvenlafaxine succinate 50mg,
Terminated
- Hot Flashes
- Breast Neoplasms
- Desvenlafaxine succinate 100mg
- +2 more
-
Goyang, Gyeonggi-do, Korea, Republic of
- +2 more
Sep 18, 2019